Genfit S.A.

Status: Publicly traded

Direct answer

Genfit S.A. is publicly traded on PAR under the ticker GNFT.PA.

Genfit S.A. operates as a biopharmaceutical enterprise, concentrating its efforts on discovering and developing both therapeutic candidates and diagnostic solutions for metabolic and liver-related ailments. Its current pipeline includes Elafibranor, which is progressing through Phase 3 clinical trials for the treatment of primary biliary cholangitis (PBC). The firm is additionally engaged in advancing the NIS4...

Can you invest in Genfit S.A.?

Yes. Genfit S.A. trades publicly on PAR as GNFT.PA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Genfit S.A.

Detailed equity research is provided by MarketSnap.